GlassScriptPhysician profile
Ali A Malik
NPI 1225391592
$7,290.61
in general payments reported to CMS, 2019-2025
26 companies · $1,379 in 2025
The $1,379 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,673 · 2020: $312 · 2021: $2,015 · 2022: $458 · 2023: $829 · 2024: $624 · 2025: $1,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,759 · Travel and Lodging: $72.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,759.35 |
| Travel and Lodging | $72.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,390.61 | 2019-2023 | Eluvia, Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered |
| Inari Medical, INC. | $1,193.69 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $723.23 | 2019-2024 | Azur Cx Detachable, Navicross |
| Penumbra, INC. | $656.87 | 2022-2025 | Indigo System, Penumbra System |
| Vertos Medical, INC. | $551.89 | 2021 | |
| Angiodynamics, INC. | $455.12 | 2020-2025 | Alphavac, Auryon Laser System 100-120 Vac, Solero |
| Shockwave Medical, INC | $287.96 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Trisalus Life Sciences, INC. | $263.33 | 2021-2023 | Trinav Infusion System |
| Medtronic, INC. | $262.00 | 2021-2025 | Kyphon Express II Kyphopak Tray, Emprint, Abre |
| Philips North America LLC | $245.88 | 2021-2025 | Philips Laser System |
| Imperative Care, INC | $241.15 | 2023-2025 | Symphony Catheter, Zoom 88-T Large Distal Platform |
| Cook Incorporated | $140.85 | 2020 | |
| Bard Peripheral Vascular, INC. | $128.51 | 2021 | |
| Galderma Laboratories, L.P. | $127.24 | 2025 | Nemluvio |
| Pfizer INC. | $105.86 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $92.65 | 2023 | |
| Krystal Biotech INC | $69.45 | 2024 | Vyjuvek |
| Baylis Medical Technologies INC. | $64.22 | 2025 | |
| Cordis US Corp. | $64.09 | 2023-2025 | Mynx Control, Saber |
| Surmodics, INC. | $54.95 | 2024 | Pounce Thrombectomy, Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Clinical Technology, INC | $44.80 | 2025 | Vascular Product |
| Asahi Intecc USA, INC. | $35.91 | 2025 | Asahi Peripheral Vascular Wires |
| Pacira Pharmaceuticals Incorporated | $25.88 | 2025 | Exparel, Iovera |
| Abbott Laboratories | $25.73 | 2025 | Perclose Prostyle |
| Valinor Pharma, LLC | $20.38 | 2023 | Movantik |
| Cook Medical LLC | $18.36 | 2024 | Cook Celect |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.